BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:20 PM
 | 
Feb 20, 2007
 |  BC Extra  |  Clinical News

BioMarin's 6R-BH4 misses Phase IIa endpoint

BioMarin (BMRN; SWX:BMRN) said 6R-BH4 missed the primary endpoint of a significant reduction in systolic blood pressure (SBP) from baseline to week...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >